Product Information
PANTOPRAZOLE SOD DR 40 MG TAB is a generic product labeled by Quallent Pharmaceuticals Health LLC, priced at $0.0358 per EA under NDC 82009001110. Its NADAC has been published 91 times since Jan 8, 2025.
FDA first approved this application on Sep 10, 2014. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
40 mg/1
Manufacturer
Quallent Pharmaceuticals Health LLCNDC
82009001110
Classification
Generic
Dosage Form
TABLET, DELAYED RELEASE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
PANTOPRAZOLE SODIUMApproval Type
Generic (ANDA)
FDA Application
ANDA202882FDA Approved
9/10/2014
TE Code
AB
On Market Since
6/6/2022
Pharmacological Classes
Price Statistics
The NADAC for PANTOPRAZOLE SOD DR 40 MG TAB has been published 91 times since Jan 8, 2025, and over the history we have for it it has declined 12.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0358 per EA |
|---|---|
| All-time high | $0.0407 (Jan 15, 2025) |
| All-time low | $0.0352 (Aug 19, 2026) |
| 52-week high | $0.0371 |
| 52-week low | $0.0352 |
| Median price | $0.0361 |
| Average price | $0.0366 |
| Largest weekly change | -12.8% (Jan 22, 2025) |
| Weeks tracked | 91 |
| Tracking since | Jan 8, 2025 |
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Quallent Pharmaceuticals Health LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
PANTOPRAZOLE market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Proton Pump Inhibitor class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of PANTOPRAZOLE SOD DR 40 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for PANTOPRAZOLE SOD DR 40 MG TAB, manufactured by Quallent Pharmaceuticals Health LLC, is $0.0358 per EA (NDC 82009001110), effective Sep 30, 2026.
How has the price of PANTOPRAZOLE SOD DR 40 MG TAB changed over time?
Over the history we have for it, the NADAC for PANTOPRAZOLE SOD DR 40 MG TAB has declined 12.1%. It has been tracked across 91 weekly CMS publications since Jan 8, 2025.
What are the highest and lowest recorded NADAC prices for PANTOPRAZOLE SOD DR 40 MG TAB?
Since Jan 8, 2025, the NADAC for PANTOPRAZOLE SOD DR 40 MG TAB has ranged from a low of $0.0352 (Aug 19, 2026) to a high of $0.0407 (Jan 15, 2025), with a median of $0.0361 per EA.
Are there cheaper alternatives to PANTOPRAZOLE SOD DR 40 MG TAB?
3 manufacturers publish a NADAC-priced product with the same active ingredient and strength as PANTOPRAZOLE SOD DR 40 MG TAB in a comparable dosage form, but none are currently priced below it.
Who manufactures PANTOPRAZOLE SOD DR 40 MG TAB?
PANTOPRAZOLE SOD DR 40 MG TAB (NDC 82009001110) is labeled by Quallent Pharmaceuticals Health LLC, and CMS classifies it as a generic product.